B. Coûts-Économiques, .. , and I. , 36 C. Programmes nationaux, p.40

.. Chez-le-sujet-diabétique, 42 a. Contre-régulation dans le diabète de type 1, p.42

I. , O. , B. Objectif, .. , I. Matériels-et-méthodes et al., 55 C. Objectifs secondaires, C. Population cible, p.57

.. Analyse-statistique and C. Le, 58 F. Aspects réglementaires, 58 III. Résultats : Les Vosges et, p.59

V. Dans-les, la répartition des HS sur le nycthémère est presque répartie en quatre quarts. La matinée, de 07-13h, est légèrement plus fréquente avec 36% des évènements contre

À. Nancy, horaire de survenue de l'hypoglycémie est beaucoup plus fréquent durant la matinée avec 26 patients soit près de 46%. En revanche, la nuit profonde est représentée par 12 patients ce qui la place en deuxième place à près de 21%

. La-période-de-jeûne, 6h est moins prononcée ici avec 18 patients soit 32% des situations Un jeûne de 3 à 6h est présent chez 16 (28,6%) patients et seulement 10

V. Dans-les, nous avons pris en charge 86 HS chez des patients diabétiques (DT1 et DT2) L'extrapolation sur une année donnerait 141 HS soit un taux d'incidence d'une HS, ayant nécessité l'aide d'un tiers, 2014.

L. 'insulinothérapie, le traitement le plus pourvoyeur d'HS, est présente chez 89,5% des patients dont 26

4. Dans-près-de, erreur diététique, engendrant une inadéquation entre l'apport glucidique et les posologies des traitements antidiabétiques Mais dans près de 40% des cas, il n'y a pas de circonstances aiguës retrouvées. Plus de 46% des patients sont dans le coma avec une glycémie moyenne de 48 ? 33 mg Cela justifie les 90,7% d'intervention dont 55,8% par un SMUR. La glycémie moyenne lors de l'arrivée des secours est de 51 ? 37 mg, seulement 45,3% des patients ont pu bénéficier d'un resucrage per os avant la prise en charge des secours. Le resucrage IV est la modalité la plus employée par les secours avec 62

D. Budnitz, M. Lovegrove, N. Shehab, and C. Richards, Emergency Hospitalizations for Adverse Drug Events in Older Americans, New England Journal of Medicine, vol.365, issue.21, pp.2002-2014, 2011.
DOI : 10.1056/NEJMsa1103053

B. Vergès, J. Brun, C. Tawil, B. Alexandre, and V. Kerlan, Strategies for insulin initiation: insights from the French LIGHT observational study, Diabetes/Metabolism Research and Reviews, vol.29, issue.43, pp.97-105
DOI : 10.1016/j.clinthera.2007.07.004

K. Lipska, J. Ross, Y. Wang, S. Inzucchi, K. Minges et al., National trends in US hospital admissions for hyperglycemia and hypoglycemia among Medicare beneficiaries, JAMA Intern Med. 2014, vol.174, issue.7, pp.1116-1140, 1999.

G. Danaei, M. Finucane, Y. Lu, G. Singh, M. Cowan et al., National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2??7 million participants, The Lancet, vol.378, issue.9785, pp.31-40, 2011.
DOI : 10.1016/S0140-6736(11)60679-X

P. Ricci, P. Blotière, A. Weill, D. Simon, P. Tuppin et al., Diabète traité en France : quelles évolutions entre, Bull Epidémiol Hebd, pp.42-43425, 2000.

. Institut-de-veille-sanitaire, Diabète : généralités et chiffres clés Available from: http://www.invs.sante.fr/Dossiers-thematiques/Maladies-chroniques-et- traumatismes

L. Mandereau-bruno, P. Denis, A. Fagot-campagna, and S. Fosse-edorh, Prévalence du diabète traité pharmacologiquement et disparités territoriales en France en 2012, Bull Epidémiol Hebd, pp.30-31493, 2014.

. Institut-de-veille-sanitaire, Prévalence et incidence du diabète Available from: http://www.invs.sante.fr/Dossiers-thematiques/Maladies-chroniques-et- traumatismes

. Institut-de-veille-sanitaire, Données épidémiologiques Available from: http://www.invs.sante.fr/Dossiers-thematiques/Maladies-chroniques-et- traumatismes

A. Fagot-campagna, S. Fosse, C. Roudier, I. Romon, A. Penfornis et al., Caractéristiques, risque vasculaire et complications chez les personnes diabétiques en France métropolitaine : d'importantes évolutions entre Entred, Bull Epidemiol Hebd, pp.42-43450, 2001.

F. Assogba, C. Couchoud, T. Hannedouche, E. Villar, L. Frimat et al., Stengel B; French Renal Epidemiology and Information Network (REIN) Registry. Trends in the epidemiology and care of diabetes mellitus-related end-stage renal disease in France, pp.718-746, 2007.

S. Fosse, A. Chatelus, S. Feldman-billard, P. Massin, C. Druet et al., Prévalence de la déficience visuelle grave (DVG) chez les personnes diabétiques en France métropolitaine en, Congrès de la Société francophone du diabète, pp.20-23, 2008.
DOI : 10.1016/s1262-3636(12)71008-x

P. Lecomte, L. Crinière, A. Fagot-campagna, C. Druet, and C. Fuhrman, Underdiagnosis of obstructive sleep apnoea syndrome in patients with type 2 diabetes in France: ENTRED 2007, Diabetes & Metabolism, vol.39, issue.2, pp.139-186, 2013.
DOI : 10.1016/j.diabet.2012.10.004

C. Fuhrman, X. Nguyen, B. Fleury, M. Boussac-zarebska, C. Druet et al., Le syndrome d'apnées du sommeil en France : un syndrome fréquent et sousdiagnostiqué, BEH, pp.44-45510, 2012.

I. Bourdel-marchasson, C. Druet, C. Helmer, E. Eschwège, P. Le-goff et al., Correlates of health-related quality of life in French people with type 2 diabetes, Diabetes Research and Clinical Practice, vol.101, issue.2, pp.226-261, 2013.
DOI : 10.1016/j.diabres.2013.05.011

I. Bourdel-marchasson, A. Tulon, M. Erpelding, P. Lecomte, P. Vexiau et al., Fagot-Campagna A, pour le comité scientifique d'Entred 2007-2010. La qualité de vie des diabétiques de type 2 vivant en France métropolitaine : de multiples facteurs associés, Bull Epidémiol Hebd, vol.2, pp.17-20, 2007.

A. Nicolucci, K. Burns, K. Holt, R. Comaschi, M. Hermanns et al., Diabetes Attitudes, Wishes and Needs second study (DAWN2 TM ): Cross-national benchmarking of diabetes-related psychosocial outcomes for people with diabetes

K. Burns, K. Nicolucci, A. Holt, R. Willaing, I. Hermanns et al., Diabetes Attitudes, Wishes and Needs second study (DAWN2 TM ): cross-national benchmarking indicators for family members living with people with diabetes

G. Pambianco, T. Costacou, D. Ellis, D. Becker, R. Klein et al., The 30-Year Natural History of Type 1 Diabetes Complications: The Pittsburgh Epidemiology of Diabetes Complications Study Experience, Diabetes, vol.55, issue.5, pp.1463-1472, 2006.
DOI : 10.2337/db05-1423

S. Livingstone, D. Levin, H. Looker, R. Lindsay, S. Wild et al., Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008.

]. Institut-de-veille-sanitaire-[-internet and E. Étude, Available from: http://www.invs.sante.fr/Dossiers-thematiques/Maladies-chroniques-et- traumatismes

E. Seaquist, J. Anderson, B. Childs, P. Cryer, S. Dagogo-jack et al., Hypoglycemia in Diabetes, JAMA, vol.318, issue.1, pp.1384-95, 2013.
DOI : 10.1001/jama.2017.8075

A. Alex and R. Nbs, 1-800-Diabetes V 22311. Hypoglycemia (Low Blood Glucose) [Internet] American Diabetes Association Available from:http://www.diabetes.org/living-with-diabetes/treatment-and-care/bloodglucose-control/hypoglycemia-low-blood, 2015.

P. Cryer, S. H. Davis, D. Longo, A. Fauci, and D. Kasper, Harrison's Principles of Internal Medicine, pp.3003-3009

J. Orban and C. Ichai, Complications métaboliques aiguës du diabète. Réanimation, Déc, vol.17, issue.8, pp.761-768, 2008.

J. Lachérade and S. Jacqueminet, Les conséquences de l'hypoglycémie. Annales Françaises d'Anesthésie et de Réanimation, Mai, vol.28, issue.5, pp.201-209, 2009.

H. Workgroup-on, American Diabetes Association Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia, Diabetes Care, vol.28, pp.1245-1254, 2005.

B. Ahrén, Avoiding hypoglycemia: a key to success for glucose-lowering therapy in type 2 diabetes, Vascular Health and Risk Management, vol.9, pp.155-63, 2013.
DOI : 10.2147/VHRM.S33934

S. Kanji, J. Buffie, B. Hutton, P. S. Bunting, A. Singh et al., Reliability of point-of-care testing for glucose measurement in critically ill adults*, Critical Care Medicine, vol.33, issue.12, pp.2778-2785, 2005.
DOI : 10.1097/01.CCM.0000189939.10881.60

A. Sonmez, Z. Yilmaz, G. Uckaya, S. Kilic, S. Tapan et al., The Accuracy of Home Glucose Meters in Hypoglycemia, Diabetes Technology & Therapeutics, vol.12, issue.8, pp.619-626, 2010.
DOI : 10.1089/dia.2009.0183

C. D. Critchell, V. Savarese, A. Callahan, C. Aboud, S. Jabbour et al., Accuracy of bedside capillary blood glucose measurements in critically ill patients, Intensive Care Medicine, vol.113, issue.Suppl A, pp.2079-2784, 2007.
DOI : 10.1177/000456329503200101

H. Gin, V. Rigalleau, and C. Gonzalez, Diagnostic des hypoglyc??mies de l???adulte, Médecine des Maladies Métaboliques, 2011.
DOI : 10.1016/S1957-2557(11)70267-X

P. Cryer, L. Axelrod, A. Grossman, S. Heller, V. Montori et al., Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline, The Journal of Clinical Endocrinology & Metabolism, vol.94, issue.3, pp.709-737, 2009.
DOI : 10.1210/jc.2008-1410

P. Cryer, S. Davis, and H. Shamoon, Hypoglycemia in diabetes. Diabetes Care, 2003.

B. Frier and B. Fisher, Impaired hypoglycaemia awareness, Hypoglycaemia in Clinical Diabetes, pp.111-146, 1999.

N. Zammitt and B. Frier, Hypoglycemia in Type 2 Diabetes: Pathophysiology, frequency, and effects of different treatment modalities, Diabetes Care, vol.28, issue.12, pp.2948-61, 2005.
DOI : 10.2337/diacare.28.12.2948

P. Cryer, Mechanisms of sympathoadrenal failure and hypoglycemia in diabetes, Journal of Clinical Investigation, vol.116, issue.6, pp.1470-1473, 2006.
DOI : 10.1172/JCI28735

V. Briscoe and S. Davis, Hypoglycemia in Type 1 and Type 2 Diabetes: Physiology, Pathophysiology, and Management, Clinical Diabetes, vol.24, issue.3, pp.115-136, 2006.
DOI : 10.2337/diaclin.24.3.115

R. Radermecker and A. Scheen, Hypoglycaemic coma, a feared paroxysmal phenomenon in type 1 diabetic patient, Rev Med Liege, vol.59, issue.5, pp.265-274

S. Pramming, B. Thorsteinsson, I. Bendtson, and C. Binder, Symptomatic Hypoglycaemia in 411 Type 1 Diabetic Patients, Diabetic Medicine, vol.2, issue.3, pp.217-239, 1991.
DOI : 10.2337/diab.12.1.38

J. Geddes, J. Schopman, N. Zammitt, and B. Frier, Prevalence of impaired awareness of hypoglycaemia in adults with Type 1 diabetes, Diabetic Medicine, vol.8, issue.4, 2008.
DOI : 10.2337/dc06-2556

J. Schopman, J. Geddes, and B. Frier, Prevalence of impaired awareness of hypoglycaemia and frequency of hypoglycaemia in insulin-treated Type 2 diabetes, Diabetes Research and Clinical Practice, vol.87, issue.1, pp.64-72, 2010.
DOI : 10.1016/j.diabres.2009.10.013

I. Cranston, J. Lomas, A. Maran, I. Macdonald, and S. Amiel, Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes. Lancet, Jul, vol.30344, issue.8918, pp.283-290, 1994.

C. Group, F. Turnbull, and C. Abraira, Intensive glucose control and microvascular outcomes in type 2 diabetes, Diabetologia, vol.52, issue.11, pp.2288-2298, 2009.

A. Chico, P. Vidal-rios, M. Subirà, and A. Novials, The Continuous Glucose Monitoring System Is Useful for Detecting Unrecognized Hypoglycemias in Patients With Type 1 and Type 2 Diabetes but Is Not Better Than Frequent Capillary Glucose Measurements for Improving Metabolic Control, Diabetes Care, vol.26, issue.4, pp.1153-1157, 2003.
DOI : 10.2337/diacare.26.4.1153

C. Currie, C. Morgan, C. Poole, P. Sharplin, M. Lammert et al., Multivariate models of health-related utility and the fear of hypoglycemia in people with diabetes

G. Leese, J. Wang, and J. Broomhall, Frequency of Severe Hypoglycemia Requiring Emergency Treatment in Type 1 and Type 2 Diabetes: A population-based study of health service resource use, Diabetes Care, vol.26, issue.4, pp.1176-1180, 2003.
DOI : 10.2337/diacare.26.4.1176

K. Fischer, J. Lees, and J. Newman, Hypoglycemia in Hospitalized Patients, New England Journal of Medicine, vol.315, issue.20, pp.1245-1250, 1986.
DOI : 10.1056/NEJM198611133152002

R. Malouf and J. Brust, Hypoglycemia: Causes, neurological manifestations, and outcome, Annals of Neurology, vol.291, issue.5, pp.421-430, 1985.
DOI : 10.7326/0003-4819-98-2-219

V. Marks and J. Teale, DRUG-INDUCED HYPOGLYCEMIA, Endocrinology and Metabolism Clinics of North America, vol.28, issue.3, pp.555-577, 1999.
DOI : 10.1016/S0889-8529(05)70088-8

G. Service, G. Thompson, and F. Service, Hyperinsulinemic Hypoglycemia with Nesidioblastosis after Gastric-Bypass Surgery, New England Journal of Medicine, vol.353, issue.3, pp.249-54, 2005.
DOI : 10.1056/NEJMoa043690

H. Gerstein, M. Miller, R. Byington, D. Goff, . Jr et al., Effects of intensive glucose lowering in type 2 diabetes, N Engl J Med, vol.58, issue.24, pp.2545-59, 2008.

C. Currie, J. Peters, A. Tynan, M. Evans, R. Heine et al., Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study, The Lancet, vol.375, issue.9713, pp.481-89, 2010.
DOI : 10.1016/S0140-6736(09)61969-3

N. Gao, P. Seshasai, S. Gobin, R. Kaptoge, S. et al., Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease : a collaborative meta-analysis of 102 prospectives studies, Emerging risk factors collaboration, pp.2215-22958, 2010.

S. Zoungas, A. Patel, and J. Chalmers, Severe Hypoglycemia and Risks of Vascular Events and Death, New England Journal of Medicine, vol.363, issue.15, pp.1410-1418, 2010.
DOI : 10.1056/NEJMoa1003795

S. Feldman-billard, P. Massin, T. Meas, P. Guillausseau, and E. Heron, Hypoglycemia-Induced Blood Pressure Elevation in Patients With Diabetes, Archives of Internal Medicine, vol.170, issue.9, pp.829-860, 2010.
DOI : 10.1001/archinternmed.2010.98

C. Desouza, G. Bolli, and V. Fonseca, Hypoglycemia, Diabetes, and Cardiovascular Events, Diabetes Care, vol.33, issue.6, pp.1389-1394, 2010.
DOI : 10.2337/dc09-2082

URL : http://care.diabetesjournals.org/content/diacare/33/6/1389.full.pdf

G. Gilles, A. Woodward, I. Casson, and P. Weston, Cardiac arrhythmia and nocturnal hypoglycaemia in type 1 diabetes???the ???dead in bed??? syndrome revisited, Diabetologia, vol.24, issue.1, pp.42-47, 2009.
DOI : 10.1093/qjmed/hcm072

L. Landstedt-hallin, A. Englund, U. Adamson, and P. E. Lins, Increased QT dispersion during hypoglycaemia in patients with type 2 diabetes mellitus, Journal of Internal Medicine, vol.352, issue.3, pp.299-307, 1999.
DOI : 10.1007/BF00176778

R. Nematollahi, L. Kitabchi, A. Stentz, F. Wan, J. Larijani et al., Proinflammatory cytokines in response to insulin-induced hypoglycemic stress in healthy subjects, Metabolism, vol.58, issue.4, pp.443-491, 2009.
DOI : 10.1016/j.metabol.2008.10.018

A. Vinik, R. Maser, B. Mitchell, and R. Freeman, Diabetic Autonomic Neuropathy, Diabetes Care, vol.26, issue.5, pp.1553-79, 2003.
DOI : 10.2337/diacare.26.5.1553

B. Bauduceau, J. Doucet, and L. Bordier, Les hypoglyc??mies chez les diab??tiques ??g??s??: cons??quences sur les fonctions cognitives, M??decine des Maladies M??taboliques, vol.5, issue.4, pp.383-87, 2011.
DOI : 10.1016/S1957-2557(11)70270-X

D. Perantie, A. Lim, J. Wu, P. Weaver, S. Warren et al., Effects of prior hypoglycemia and hyperglycemia on cognition in children with type 1 diabetes mellitus. Pediatr Diabetes, pp.87-95, 2008.

. Group, A. Jacobson, G. Musen, C. Ryan, N. Silvers et al., Long-term effect of diabetes and its treatment on cognitive function, Diabetes Control and Complications Trial, pp.1842-52, 2007.

K. Yaffe, C. Falvey, N. Hamilton, T. Harris, E. Simonsick et al., Association Between Hypoglycemia and Dementia in a Biracial Cohort of Older Adults With Diabetes Mellitus, JAMA Internal Medicine, vol.173, issue.14, pp.1300-1306, 2013.
DOI : 10.1001/jamainternmed.2013.6176

I. Feinkohl, P. Aung, M. Keller, C. Robertson, J. Morling et al., Severe Hypoglycemia and Cognitive Decline in Older People With Type 2 Diabetes: The Edinburgh Type 2 Diabetes Study, Diabetes Care, vol.37, issue.2, pp.507-522, 2014.
DOI : 10.2337/dc13-1384

S. Laing, A. Swerdlow, S. Slater, J. Botha, A. Burden et al., The British Diabetic Association Cohort Study, I: all-cause mortality in patients with insulin-treated diabetes mellitus, Diabetic Medicine, vol.8, issue.6, pp.459-65, 1999.
DOI : 10.2337/diacare.8.2.114

D. Cox, D. Ford, L. Gonder-frederick, W. Clarke, R. Mazze et al., Driving Mishaps Among Individuals With Type 1 Diabetes: A prospective study, Diabetes Care, vol.32, issue.12, pp.2177-80, 2009.
DOI : 10.2337/dc08-1510

A. Green, K. Fox, S. Grandy, . Shield-study, and . Group, Self-reported hypoglycemia and impact on quality of life and depression among adults with type 2 diabetes mellitus, Diabetes Research and Clinical Practice, vol.96, issue.3, pp.313-321, 2012.
DOI : 10.1016/j.diabres.2012.01.002

M. Peyrot, K. Burns, M. Davies, A. Forbes, N. Hermanns et al., Diabetes Attitudes Wishes and Needs 2 (DAWN2): A multinational, multi-stakeholder study of psychosocial issues in diabetes and person-centred diabetes care, Diabetes Research and Clinical Practice, vol.99, issue.2, pp.174-84, 2013.
DOI : 10.1016/j.diabres.2012.11.016

F. Lapostolle, N. Hamdi, J. D. Capette, A. Avenel, S. Darricau et al., ??ducation de l???entourage des patients diab??tiques??: ??tude EDUCATED, La Presse M??dicale, vol.39, issue.10, pp.1096-1103, 2010.
DOI : 10.1016/j.lpm.2010.06.004

M. Touraine, C. B. Circulaire, . N°-dgos-/-r2-/, and . Dgscgc, relative à l'application de l'arrêté du 24 avril 2009 relatif à la mise en oeuvre du référentiel portant sur l'organisation du secours à personne et de l'aide médicale urgente, 2015.

. Inventaire, Département des Vosges. Ministère de l'Agriculture, p.110, 1973.

T. Guillaume, Population : projections. Horizon 2030 : une population moins nombreuse et plus âgée

N. Chevalier and P. Böhme, Incidence, predictive factors and direct costs of severe hypoglycaemia-results from the prospective HYPO.15. The 51st EASD Annual Meeting, Sept, 2015.

M. Allicar, F. Mégas, S. Houzard, A. Baroux, L. Thai et al., Frequency and costs of hospital stays for hypoglycemia in France in 1995, Presse Med, vol.29, issue.12, pp.657-61, 2000.

S. Halimi, P. Trouillet, H. Spath, J. Sacareau, and M. Baudrant-boga, O9 Fr??quence, typologie des patients et co??t m??dico-??conomique des hypoglyc??mies iatrog??nes s??v??res chez des diab??tiques de type 2 sur un territoire de sant?? en France, Diabetes & Metabolism, vol.39, pp.2-3
DOI : 10.1016/S1262-3636(13)71621-5

B. Cariou, P. Fontaine, E. Eschwege, M. Lièvre, D. Gouet et al., Frequency and predictors of confirmed hypoglycaemia in type 1 and insulin-treated type 2 diabetes mellitus patients in a real-life setting: Results from the DIALOG study, Diabetes & Metabolism, vol.41, issue.2, pp.116-141
DOI : 10.1016/j.diabet.2014.10.007

S. Liatis, M. Mylona, S. Kalopita, A. Papazafiropoulou, S. Karamagkiolis et al., Hypoglycaemia requiring medical assistance in patients with diabetes: A prospective multicentre survey in tertiary hospitals, Diabetes & Metabolism, vol.41, issue.2, 2015.
DOI : 10.1016/j.diabet.2014.10.006

M. Miller, J. Williamson, H. Gerstein, R. Byington, W. Cushman et al., Effects of Randomization to Intensive Glucose Control on Adverse Events, Cardiovascular Disease, and Mortality in Older Versus Younger Adults in the ACCORD Trial, Diabetes Care, vol.37, issue.3, pp.634-677, 2014.
DOI : 10.2337/dc13-1545

A. Gold, K. Macleod, and B. Frier, Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia. Diabetes Care, pp.697-703, 1994.

I. Mühlhauser, H. Overmann, R. Bender, U. Bott, and M. Berger, Risk factors of severe hypoglycaemia in adult patients with Type I diabetes - a prospective population based study, Diabetologia, vol.41, issue.11, pp.1274-82, 1998.
DOI : 10.1007/s001250051065

. Advance-collaborative-group, A. Patel, S. Macmahon, C. J. Neal, B. Billot et al., Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes, N Engl J Med, vol.358, issue.24, pp.2560-72, 2008.

M. Riddle, Effects of Intensive Glucose Lowering in the Management of Patients With Type 2 Diabetes Mellitus in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial, Circulation, vol.122, issue.8, pp.844-850, 2010.
DOI : 10.1161/CIRCULATIONAHA.110.960138

W. Duckworth, C. Abraira, T. Moritz, D. Reda, N. Emanuele et al., Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes, New England Journal of Medicine, vol.360, issue.2, pp.129-168, 2009.
DOI : 10.1056/NEJMoa0808431

A. Wright, C. Cull, K. Macleod, R. Holman, and . Group, Hypoglycemia in Type 2 diabetic patients randomized to and maintained on monotherapy with diet, sulfonylurea, metformin, or insulin for 6 years from diagnosis: UKPDS73, Journal of Diabetes and its Complications, vol.20, issue.6, pp.395-401, 2006.
DOI : 10.1016/j.jdiacomp.2005.08.010

D. Fronzo, R. Hissa, M. Garber, and A. , The Efficacy and Safety of Saxagliptin When Added to Metformin Therapy in Patients With Inadequately Controlled Type 2 Diabetes With Metformin Alone, Diabetes Care, vol.32, issue.9, pp.1649-1655, 2009.
DOI : 10.2337/dc08-1984

. Group, Efficacy and safety of adding the dipeptidyl peptidase-4 inhibitor alogliptin to metformin therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy:a multicenter, randomized, double-blind, placebo controlled study, Int J Clin Pract, vol.63, issue.1, pp.46-55, 2009.

B. Detournay, S. Halimi, J. Robert, C. Deschaseaux, and S. Dejager, Hypoglycemia hospitalization frequency in patients with type 2 diabetes mellitus: a comparison of dipeptidyl peptidase 4 inhibitors and insulin secretagogues using the French health insurance database, Vasc Health Risk Manag, vol.11, pp.417-442, 2015.

J. Rosenstock, B. Ahrén, and F. Chow, Once-weekly GLP-1 receptor agonist albiglutide vs titrated prandial lispro added on to titrated basal glargine in type 2 diabetes (T2D) uncontrolled on glargine plus oral agents: similar glycemic control weight loss and less hypoglycemia, Diabetes, vol.61, p.15, 2012.

T. Vilsbøll, J. Rosenstock, and H. Yki-järvinen, Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes, Diabetes, Obesity and Metabolism, vol.287, issue.(Suppl. 1), pp.167-177, 2010.
DOI : 10.7326/0003-4819-143-8-200510180-00006

M. Hammer, M. Lammert, S. Mejías, W. Kern, and B. Frier, Costs of managing severe hypoglycaemia in three European countries, Journal of Medical Economics, vol.12, issue.4, pp.281-90, 2009.
DOI : 10.3111/13696990903336597

B. Quilliam, J. Simeone, A. Ozbay, and S. Kogut, The incidence and costs of hypoglycemia in type 2 diabetes, Am J Manag Care, vol.17, issue.10, pp.673-80, 2011.

M. Franciosi, G. Lucisano, R. Amoretti, F. Capani, D. Bruttomesso et al., Costs of treatment and complications of adult type 1 diabetes. Nutr Metab Cardiovasc Dis, pp.606-617, 2013.

M. Peyrot, A. Barnett, L. Meneghini, and P. Schumm-draeger, Factors associated with injection omission/non-adherence in the Global Attitudes of Patients and Physicians in Insulin Therapy study. Diabetes Obese Metab, 2012.

S. Carstens and M. Sprehn, Prehospital treatment of severe hypoglycaemia: a comparison of intramuscular glucagon and intravenous glucose, Prehosp Disaster Med, vol.13, pp.2-444, 1998.

M. Howell and H. Guly, A comparison of glucagon and glucose in prehospital hypoglycaemia., Emergency Medicine Journal, vol.14, issue.1, pp.30-32, 1997.
DOI : 10.1136/emj.14.1.30

R. Vukmir, P. Paris, and D. Yealy, Glucagon: Prehospital therapy for hypoglycemia. Annals of Emergency Medicine, pp.375-384, 1991.

M. Vermeulen, M. Klompas, J. Ray, C. Mazza, and L. Morrison, Subcutaneous glucagon may be better than oral glucose for prehospital treatment of symptomatic hypoglycemia. Diabetes Care, pp.2472-2475, 2003.

C. Pollack, Utility of glucagon in the emergency department, The Journal of Emergency Medicine, vol.11, issue.2, pp.195-205, 1993.
DOI : 10.1016/0736-4679(93)90519-D

G. Marri, G. Cozzolono, and R. Palumbo, Glucagon in sulphonylurea hypoglycaemia?, Lancet, vol.1, pp.303-307, 1968.

N. Briole, D. Sapir, F. Laborne, S. Manallah, G. Capitani et al., ??valuation de la prise en charge des hypoglyc??mies symptomatiques en SMUR, Journal Europ??en des Urgences, vol.22, issue.2, p.142, 2009.
DOI : 10.1016/j.jeur.2009.03.344

J. Rosenstock, G. Dailey, M. Massi-benedetti, A. Fritsche, Z. Lin et al., Reduced Hypoglycemia Risk With Insulin Glargine: A meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes, Diabetes Care, vol.28, issue.4, pp.950-955, 2005.
DOI : 10.2337/diacare.28.4.950

A. Barnett, Dosing of insulin glargine in the treatment of type 2 diabetes, Clinical Therapeutics, vol.29, issue.6, pp.987-999, 2007.
DOI : 10.1016/j.clinthera.2007.06.018

P. Böhme, E. Bertin, E. Cosson, and C. N. , Fear of hypoglycaemia in patients with type 1 diabetes: Do patients and diabetologists feel the same way?, Diabetes & Metabolism, vol.39, issue.1, pp.63-70, 2013.
DOI : 10.1016/j.diabet.2012.10.006

S. Little, J. Shaw, and P. Home, Hypoglycemia Rates with Basal Insulin Analogs, Diabetes Technology & Therapeutics, vol.13, issue.S1, pp.53-64, 2011.
DOI : 10.1089/dia.2011.0022

M. Maiorino, M. Petrizzo, A. Capuano, D. Giugliano, and K. Esposito, The development of new basal insulins: is there any clinical advantage with their use in type 2 diabetes? Expert Opin Biol Ther, pp.799-808, 2014.

B. Schaan and R. Scheffel, Modern insulins, old paradigms and pragmatism: choosing wisely when deciding how to treat type 1 diabetes, Diabetology & Metabolic Syndrome, vol.96, issue.1, p.35, 2015.
DOI : 10.1016/j.diabres.2011.11.006

R. Becker, R. Dahmen, K. Bergmann, A. Lehmann, T. Jax et al., New insulin glargine 300 units?mL?1 provides a more even activity profile and prolonged glycemic control at steady state compared with insulin glargine 100 units?mL?1, Diabetes Care, vol.38, pp.637-643, 2015.